Ctc Alternative Strategies, Ltd. / ACAD
Ctc Alternative Strategies, Ltd.’s Acadia Pharmaceuticals Inc Position
Does Ctc Alternative Strategies, Ltd. own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 55.1K shares worth $1M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q4 2024
Shares
55.1K
% of Portfolio
+1.22%
Quarters Held
1
position exited
Position History ACAD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 55.1K | $1M | +1.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ctc Alternative Strategies, Ltd.’s full portfolio or all institutional holders of ACAD.